{"pmid":32467503,"title":"Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report.","text":["Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report.","Am J Gastroenterol","La Mura, Vincenzo","Artoni, Andrea","Martinelli, Ida","Rossio, Raffaella","Gualtierotti, Roberta","Ghigliazza, Gabriele","Fusco, Stefano","Ierardi, Anna Maria","Andrisani, Maria Carmela","Carrafiello, Gianpaolo","Peyvandi, Flora","32467503"],"journal":"Am J Gastroenterol","authors":["La Mura, Vincenzo","Artoni, Andrea","Martinelli, Ida","Rossio, Raffaella","Gualtierotti, Roberta","Ghigliazza, Gabriele","Fusco, Stefano","Ierardi, Anna Maria","Andrisani, Maria Carmela","Carrafiello, Gianpaolo","Peyvandi, Flora"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467503","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.14309/ajg.0000000000000711","topics":["Case Report"],"weight":1,"_version_":1668167109988843520,"score":9.490897,"similar":[{"pmid":32390931,"pmcid":"PMC7188982","title":"A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.","text":["A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.","We report a case of a 75-year-old woman diagnosed with severe coronavirus disease 2019 (COVID-19) complicated by acute cerebral infarction. The patient was admitted to our hospital on 5 February 2020 with severe COVID-19. On 20 February 2020, she was diagnosed with concomitant acute cerebral infarction via head computed tomography (CT) and deep vein thrombosis in both lower limbs. After symptomatic and supportive treatments, the patient was discharged on 13 March 2020. She will comply with quarantine for another 2 weeks and receive rehabilitation training from a specialist doctor. Cerebral infarction should be considered and promptly managed in patients with COVID-19.","Front Neurol","Zhou, Bo","She, Jianqing","Wang, Yadan","Ma, Xiancang","32390931"],"abstract":["We report a case of a 75-year-old woman diagnosed with severe coronavirus disease 2019 (COVID-19) complicated by acute cerebral infarction. The patient was admitted to our hospital on 5 February 2020 with severe COVID-19. On 20 February 2020, she was diagnosed with concomitant acute cerebral infarction via head computed tomography (CT) and deep vein thrombosis in both lower limbs. After symptomatic and supportive treatments, the patient was discharged on 13 March 2020. She will comply with quarantine for another 2 weeks and receive rehabilitation training from a specialist doctor. Cerebral infarction should be considered and promptly managed in patients with COVID-19."],"journal":"Front Neurol","authors":["Zhou, Bo","She, Jianqing","Wang, Yadan","Ma, Xiancang"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32390931","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3389/fneur.2020.00296","keywords":["covid-19","ct","acute cerebral infarction","case","thrombosis"],"topics":["Case Report"],"weight":1,"_version_":1666528580061888512,"score":51.014614},{"pmid":32335249,"pmcid":"PMC7177144","title":"Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk.","text":["Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk.","Little or nothing is known about the correlation between the upper limb deep vein thrombosis (UL-DVT) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the increased risk of UL-DVT in 3 patients with SARS-CoV-2 who require continuous positive airway pressure with a hood and the need for early adequate antithrombotic prophylaxis.","Ann Vasc Surg","Bozzani, Antonio","Arici, Vittorio","Franciscone, Mila Maria","Danesino, Vittorio","Cascina, Alessandro","Ticozzelli, Giulia","Ragni, Franco","32335249"],"abstract":["Little or nothing is known about the correlation between the upper limb deep vein thrombosis (UL-DVT) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the increased risk of UL-DVT in 3 patients with SARS-CoV-2 who require continuous positive airway pressure with a hood and the need for early adequate antithrombotic prophylaxis."],"journal":"Ann Vasc Surg","authors":["Bozzani, Antonio","Arici, Vittorio","Franciscone, Mila Maria","Danesino, Vittorio","Cascina, Alessandro","Ticozzelli, Giulia","Ragni, Franco"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335249","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.avsg.2020.04.037","topics":["Case Report"],"weight":1,"_version_":1666138494136745984,"score":48.413647},{"pmid":32399449,"pmcid":"PMC7213837","title":"Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?","text":["Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?","Coronavirus disease 19 (COVID-19) is a worldwide infection which was recently declared a global health emergency by the WHO Emergency Committee. The most common symptoms are fever and cough, which can progress to pneumonia, acute respiratory distress syndrome (ARDS) and/or end-organ failure. Risk factors associated with ARDS and death are older age, comorbidities (e.g., hypertension, diabetes, hyperlipidaemia), neutrophilia, and organ and coagulation dysfunction. Disseminated intravascular coagulation and coagulopathy can contribute to death. Anticoagulant treatment is associated with decreased mortality in severe COVID-19 pneumonia. In this report we describe two patients with COVID-19 pneumonia who developed venous thromboembolism. LEARNING POINTS: Deep vein thrombosis and pulmonary embolism can occur in patients with COVID-19 pneumonia.Low-molecular-weight heparin prophylaxis does not decrease the risk of venous thromboembolism (VTE) in COVID-19 pneumonia.In the presence of clinical signs and/or suspicion of VTE, compression ultrasound and echocardiography should be always performed, irrespective of disease stage.","Eur J Case Rep Intern Med","Poggiali, Erika","Bastoni, Davide","Ioannilli, Eva","Vercelli, Andrea","Magnacavallo, Andrea","32399449"],"abstract":["Coronavirus disease 19 (COVID-19) is a worldwide infection which was recently declared a global health emergency by the WHO Emergency Committee. The most common symptoms are fever and cough, which can progress to pneumonia, acute respiratory distress syndrome (ARDS) and/or end-organ failure. Risk factors associated with ARDS and death are older age, comorbidities (e.g., hypertension, diabetes, hyperlipidaemia), neutrophilia, and organ and coagulation dysfunction. Disseminated intravascular coagulation and coagulopathy can contribute to death. Anticoagulant treatment is associated with decreased mortality in severe COVID-19 pneumonia. In this report we describe two patients with COVID-19 pneumonia who developed venous thromboembolism. LEARNING POINTS: Deep vein thrombosis and pulmonary embolism can occur in patients with COVID-19 pneumonia.Low-molecular-weight heparin prophylaxis does not decrease the risk of venous thromboembolism (VTE) in COVID-19 pneumonia.In the presence of clinical signs and/or suspicion of VTE, compression ultrasound and echocardiography should be always performed, irrespective of disease stage."],"journal":"Eur J Case Rep Intern Med","authors":["Poggiali, Erika","Bastoni, Davide","Ioannilli, Eva","Vercelli, Andrea","Magnacavallo, Andrea"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399449","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.12890/2020_001646","keywords":["covid-19 pneumonia","deep vein thrombosis","heparin","pulmonary embolism","venous thromboembolism"],"locations":["Pneumonia"],"e_drugs":["Heparin"],"topics":["Case Report"],"weight":1,"_version_":1666714494762483713,"score":45.76754}]}